knowledge -WSS

knowledge

author：hotspot 2025-09-27 19:28:09 - browse：1

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： CDC Director Mandy Cohen on transparency, trust, and health

WSS

Rise in cancer among younger people worries and puzzles doctors

UHS says company favors patients whose insurance pays more

The battle over 'scope creep' and who gets to be called 'doctor'

What to watch for from Zogenix and Amicus clinical trials

Alabama frozen embryo ruling has major implications for IVF clinics

Search called off for baby washed away in Pennsylvania flash flood

knowledge

knowledge

hotspot

Continuity nursing helped my family in our darkest PICU moments

The battle over 'scope creep' and who gets to be called 'doctor'

Medicare proposal to cover medical devices draws a mixed reaction

A new crop of companies is reshaping the health data economy

United colonoscopy coverage change 'may cost lives,' doctors say

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Walensky prepares to leave CDC — and Congress — behind

Will the FTC rein in IQVIA's health data empire?

Sports medicine is finally prioritizing gender equality

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

explore

Medicare inequities exacerbate Puerto Rico’s health disparities

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Democrats decry new health bill for going easy on private equity

The Harvard botanist who searched for psychedelics in the Amazon

leisure time

leisure time

Wikipedia

focus